Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

The Development of Inhibitors of Heparanase, a Key Enzyme Involved in Tumour Metastasis, Angiogenesis and Inflammation

Author(s): Vito Ferro, Edward Hammond and Jon K. Fairweather

Volume 4, Issue 6, 2004

Page: [693 - 702] Pages: 10

DOI: 10.2174/1389557043403729

Price: $65

Abstract

Heparanase is an endo-β-glucuronidase that degrades the glycosaminoglycan heparan sulfate, a major component of the extracellular matrix and basement membranes, and has been implicated in such processes as inflammation, angiogenesis and metastasis. The identification of inhibitors of heparanase is an attractive approach towards developing new therapeutics for metastatic tumours and chronic inflammatory diseases. This review focuses on heparanase inhibitors that have been isolated or synthesised to date. More recent developments in the understanding of heparanase structure and function that may ultimately aid in the future design of inhibitors with improved potency and specificity, are also discussed.

Keywords: heparanase, glucuronidase, heparan sulfate, metastasis, angiogenesis, inflammation, inhibitors


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy